Story perspectives

Swiss Biotech's Mitopure Shows Promise in Immune Rejuvenation

11/8/2025

33 4

Summary

Story summary

Amazentis SA, a Swiss biotech company, is testing Mitopure, a longevity supplement derived from urolithin A.
Initial clinical results suggest Mitopure may rejuvenate the immune system by improving metabolic profiles in participants' immune cells.
Researchers caution these changes are promising but require further studies to confirm health benefits.
The findings were published in Nature Aging.
Future trials will explore Mitopure's potential to enhance cancer immunotherapy.

1 of 1

Story summary

Amazentis SA, a Swiss biotech company, is testing Mitopure, a longevity supplement derived from urolithin A.
Initial clinical results suggest Mitopure may rejuvenate the immune system by improving metabolic profiles in participants' immune cells.
Researchers caution these changes are promising but require further studies to confirm health benefits.
The findings were published in Nature Aging.
Future trials will explore Mitopure's potential to enhance cancer immunotherapy.